Wedbush analyst Matthew Bryson upgrades Intel (NASDAQ:INTC) from Underperform to Neutral and raises the price target from $20 to $30.
Wedbush raised Intel (NASDAQ:INTC) price target from $20 to $30 Read Post »
Raymond James analyst Patrick Tyler Brown maintains Waste Management (NYSE:WM) with a Outperform and raises the price target from $166 to $175.
Raymond James raised Waste Management (NYSE:WM) price target from $166 to $175 Read Post »
Stifel analyst Michael Hoffman upgrades Waste Management (NYSE:WM) from Hold to Buy and raises the price target from $171 to $177.
Stifel raised Waste Management (NYSE:WM) price target from $171 to $177 Read Post »
AbbVie(NYSE:ABBV) reported Q1 adjusted earnings of $2.46 per diluted share, compared with $3.16 a year earlier. Analysts polled by Capital IQ expected $2.48. Net revenue for the quarter ended March 31 was $12.23 billion, compared with $13.54 billion a year earlier. Analysts surveyed by Capital IQ expected $12.25 billion. The company raised its adjusted earnings guidance for full-year 2023 to $10.72 to $11.12 per diluted share from $10.62 to $11.02. Analysts polled by Capital IQ expect 2023 adjusted earnings of $10.95.
AbbVie (NYSE:ABBV) Raised 2023 Adjusted Earnings Guidance Read Post »
Wells Fargo analyst Mohit Bansal maintains AbbVie (NYSE:ABBV) with a Overweight and lowers the price target from $200 to $195.
Wells Fargo lowered AbbVie (NYSE:ABBV) price target from $200 to $195 Read Post »
Piper Sandler analyst Joseph Catanzaro assumes Gilead Sciences (NASDAQ:GILD) with a Overweight rating and announces Price Target of $105.
Piper Sandler announced Gilead Sciences (NASDAQ:GILD) Price Target of $105 Read Post »
JPMorgan analyst Matthew Boss initiates coverage on Carnival (NYSE:CCL) with a Neutral rating and announces Price Target of $11.
JPMorgan announced Carnival (NYSE:CCL) Price Target of $11 Read Post »
Roth Capital analyst Rohit Kulkarni reiterates Meta Platforms (NASDAQ:META) with a Buy and raises the price target from $230 to $255.
Roth Capital raised Meta Platforms (NASDAQ:META) price target from $230 to $255 Read Post »
Boston Scientific (NYSE:BSX) Raises 2023 Adj. EPS Outlook to $1.90-$1.96 From $1.86-$1.93; Boston Scientific (NYSE:BSX) Sees 2Q Sales Up 6.5%-8.5%, Organic Sales Up 7%-9%
Needham analyst Mike Matson maintains Boston Scientific (NYSE:BSX) with a Buy and raises the price target from $56 to $57.
Needham raised Boston Scientific (NYSE:BSX) price target from $56 to $57 Read Post »
Stifel analyst Rick Wise maintains Boston Scientific (NYSE:BSX) with a Buy and raises the price target from $52 to $58.
Stifel raised Boston Scientific (NYSE:BSX) price target from $52 to $58 Read Post »
Barclays analyst Ross Sandler maintains eBay (NASDAQ:EBAY) with a Overweight and raises the price target from $56 to $59.
Barclays raised eBay (NASDAQ:EBAY) price target from $56 to $59 Read Post »